Jacques Neefjes

Active 1986–2024

179
Papers
34,938
Citations
105
h-index
175
i10-index

Citations

Citations per year for Jacques Neefjes1986: 1 citations1987: 5 citations1988: 10 citations1989: 19 citations1990: 33 citations1991: 90 citations1992: 131 citations1993: 111 citations1994: 203 citations1995: 246 citations1996: 212 citations1997: 225 citations1998: 222 citations1999: 241 citations2000: 204 citations2001: 223 citations2002: 257 citations2003: 234 citations2004: 227 citations2005: 228 citations2006: 237 citations2007: 251 citations2008: 228 citations2009: 233 citations2010: 218 citations2011: 231 citations2012: 215 citations2013: 264 citations2014: 270 citations2015: 247 citations2016: 330 citations2017: 304 citations2018: 326 citations2019: 962 citations2020: 1,098 citations2021: 1,132 citations2022: 896 citations2023: 729 citations2024: 1,069 citations2025: 442 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,091 citing papers, 28.1% of this breakdownChina: 1,455 citing papers, 10% of this breakdownGermany: 1,125 citing papers, 7.7% of this breakdownUnited Kingdom: 987 citing papers, 6.8% of this breakdownNetherlands: 864 citing papers, 5.9% of this breakdownFrance: 606 citing papers, 4.2% of this breakdownCanada: 466 citing papers, 3.2% of this breakdownItaly: 432 citing papers, 3% of this breakdownJapan: 393 citing papers, 2.7% of this breakdownAustralia: 355 citing papers, 2.4% of this breakdownSwitzerland: 354 citing papers, 2.4% of this breakdownSpain: 259 citing papers, 1.8% of this breakdown
0%28.1%Other 21.8%

Fields

  • Biochemistry, Genetics and Molecular Biology40.6%
  • Medicine29.6%
  • Immunology and Microbiology22.4%
  • Neuroscience1.6%
  • Chemistry1.2%
  • Agricultural and Biological Sciences1.2%
  • Other3.4%

Topics

  • Immunotherapy and Immune Responses7.3%
  • Immune Cell Function and Interaction5.2%
  • T-cell and B-cell Immunology3.8%
  • Cancer Immunotherapy and Biomarkers3.6%
  • Cellular transport and secretion3.1%
  • Ubiquitin and proteasome pathways2.4%
  • Other74.6%

Coauthors

All papers

Open in search
  1. Towards a systems understanding of MHC class I and MHC class II antigen presentation

    Authors: , , , - Nature reviews. Immunology 2011 cited by 1,999

  2. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

    Authors: , , , , , , , , , , , , , , , , - The Journal of Cell Biology 2006 cited by 1,704

  3. Present Yourself! By MHC Class I and MHC Class II Molecules

    Authors: , , - Trends in Immunology 2016 cited by 794

  4. New insights into the activities and toxicities of the old anticancer drug doxorubicin

    Authors: , , - FEBS Journal 2020 cited by 395

  5. Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Cell Biology 2018 cited by 365

  6. Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 cited by 393

  7. Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2019 cited by 242

  8. Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7–RILP–p150Glued and late endosome positioning

    Authors: , , , , , , , - The Journal of Cell Biology 2009 cited by 685

  9. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors

    Authors: , , , , , , , , - Current Biology 2001 cited by 804

  10. Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin

    Authors: , , , , , , , , , , , , , - Nature Communications 2013 cited by 431

  11. Mechanisms of lysosomal positioning and movement

    Authors: , - Traffic 2018 cited by 271

  12. Moving and positioning the endolysosomal system

    Authors: , - Current Opinion in Cell Biology 2017 cited by 240

  13. Anthracyclines: biosynthesis, engineering and clinical applications

    Authors: , , , , - Natural Product Reports 2021 cited by 106

  14. MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell 2012 cited by 434

  15. On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in Proteases

    Authors: , , , , , , , , , , , - Journal of the American Chemical Society 2013 cited by 360

  16. The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2020 cited by 118

  17. Uncoupling DNA damage from chromatin damage to detoxify doxorubicin

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 168

  18. SKIP‐HOPS recruits TBC1D15 for a Rab7‐to‐Arl8b identity switch to control late endosome transport

    Authors: , , , , , , , , , , , , , , , - The EMBO Journal 2020 cited by 113

  19. Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma

    Authors: , , , , , , , , , , , , , , , - Cell Host & Microbe 2015 cited by 265

  20. An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport

    Authors: , , , , , , , , , , - Cell 2016 cited by 252

  21. Retrofusion of intralumenal MVB membranes parallels viral infection and coexists with exosome release

    Authors: , , , , , , , - Current Biology 2021 cited by 76

  22. Variations in MHC Class II Antigen Processing and Presentation in Health and Disease

    Authors: , , - Annual Review of Immunology 2016 cited by 278

  23. Activation of endosomal dynein motors by stepwise assembly of Rab7–RILP–p150Glued, ORP1L, and the receptor βlll spectrin

    Authors: , , , , , , , - The Journal of Cell Biology 2007 cited by 485

  24. Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer

    Authors: , , , , - Nature Reviews Microbiology 2017 cited by 191